Publication date: Available online 11 August 2016
Source:Sleep Medicine
Author(s): Jaime M. Monti
Sleep disturbances predominantly take the form of insomnia in patients with unipolar disorder, while patients with bipolar disorder show a decreased need for sleep. Sleep impairment in these patients is a risk factor for the development of a major depressive episode and suicidal behavior. Administration of second-generation antipsychotics (SGAs) olanzapine, quetiapine and ziprasidone as augmentation therapy or monotherapy to unipolar and bipolar disorder patients, respectively, has been shown to improve sleep continuity and sleep architecture. Thus, their use by these patients could ameliorate their sleep disorder.
from #SleepMedicine via xlomafota13 on Inoreader http://ift.tt/2b1Ep4p
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου